11.03.2024 - Fourth quarter revenue increased 60% year-over-year to $44.9 million with Telehealth revenues increasing 90% versus the year-ago period.Adjusted EPS of $0.15 per share compared with $0.02 in the year-ago period.Consolidated adjusted EBITDA of $5.5 .
08.01.2024 - Revenue expected to be between $195 and $205 million, represents a 31% to 38% increase over the midpoint of 2023 guidance.Adjusted EBITDA expected to be between $18 and $22 million, representing an increase of 71% to 110% over the midpoint of 2023 . Seite 1